We sit down with Sepmag's Lluís M. Martinez, Founder & CSO, and Josep-Maria Simó, Managing Director, to discuss the current state and future of magnetic separation technology.
Immunocore Unveils Promising HIV Functional Cure Data at CROI 2025
Promising early data at CROI 2025 shows that HIV functional cure candidate, IMC-M113V, is well-tolerated and may offer prolonged viral suppression without the need for lifelong antiretroviral therapy.
The leading gene therapy company, has announced positive clinical trial results for its groundbreaking gene therapy treatment aimed at restoring vision in children with inherited retinal diseases
Kadimastem has secured shareholder approval for a merger with NLS Pharmaceutics, aiming to achieve a Nasdaq listing and advance its cell therapy treatments for amyotrophic lateral sclerosis (ALS).
IGM Biosciences Halts Lead Autoimmune Programs, Cuts Workforce by 73%
IGM Biosciences is discontinuing its lead autoimmune programs, imvotamab and IGM-2644, following disappointing clinical results, and implementing a 73% workforce reduction while reevaluating its strategic direction.
